Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect

Documenti analoghi

• Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
  di: Mochel, Fanny, et al.
  Pubblicazione: (2016)
• A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood
  di: Hainque, Elodie, et al.
  Pubblicazione: (2017)
• No effect of triheptanoin on exercise performance in McArdle disease
  di: Madsen, Karen L., et al.
  Pubblicazione: (2019)
• GLUT1 Deficiency in a Patient Diagnosed as Cerebral Palsy: Is NGS a Valuable Tool to Be Considered in All Cases of CP to Detect Underlying Genetic Disorders?
  di: Méneret, Aurélie, et al.
  Pubblicazione: (2019)
• Adult-onset Generalized Dystonia as the Main Manifestation of MEGDEL Syndrome
  di: Giron, Camille, et al.
  Pubblicazione: (2018)